| 2026-08-03 | 10-Q | 10.3 | Lease Agreement dated June 17, 2016 between the WS NV 15 Crosby Drive, LLC and the Registrant |
|---|
| 2026-08-03 | 10-Q | 10.1 | 2021 Stock Incentive Plan, as amended |
|---|
| 2026-05-05 | 10-Q | 10.4 | Employment Agreement by and between the Registrant and Jason S. Robins, dated as of April 15, 2026 |
|---|
| 2026-05-05 | 10-Q | 10.3 | Employment Agreement by and between the Registrant and David Robinson, dated as of January 20, 2026 |
|---|
| 2026-05-05 | 10-Q | 10.2 | Sublease Agreement, by and between Quanterix Corporation and the Registrant, dated as of January 1, 2026 |
|---|
| 2025-08-05 | 10-Q | 10.5 | Employment Agreement, by and between the Registrant and Namrata Saroj, dated November 3, 2024 |
|---|
| 2025-08-05 | 10-Q | 10.4 | First Amendment to Employment Agreement, by and between the Registrant and Steve Meyers, dated August 3, 2023 |
|---|
| 2025-08-05 | 10-Q | 10.3 | Employment Agreement, by and between the Registrant and Steve Meyers, dated January 27, 2023 |
|---|
| 2025-08-05 | 10-Q | 10.2 | Amended and Restated 2014 Employee Stock Purchase Plan |
|---|
| 2025-08-05 | 10-Q | 10.1 | 2021 Stock Incentive Plan, as amended |
|---|
| 2025-05-05 | 10-Q | 10.5 | Performance Stock Option Agreement by and between the Registrant and Dr. Pravin U. Dugel, dated as of February 11, 2025 |
|---|
| 2025-05-05 | 10-Q | 10.4 | Performance Stock Unit Agreement by and between the Registrant and Dr. Pravin U. Dugel, dated as of February 11, 2025 |
|---|
| 2025-05-05 | 10-Q | 10.3 | Restricted Stock Unit Agreement by and between the Registrant and Dr. Pravin U. Dugel, dated as of February 11, 2025 |
|---|
| 2025-03-03 | 10-K | 10.52 | Amendment No. 2 to the Employment Agreement by and between the Registrant and Dr. Peter Kaiser, dated as of March 1, 2025 |
|---|
| 2025-03-03 | 10-K | 10.49 | Amendment No. 1 to the Employment Agreement by and between the Registrant and Dr. Jeffrey Heier, dated as of March 1, 2025 |
|---|
| 2024-11-14 | 10-Q | 10.4 | Employment Agreement, by and between the Registrant and Todd Anderman, dated as of October 4, 2024 |
|---|
| 2024-11-14 | 10-Q | 10.3 | Amendment No. 1 to the Employment Agreement, by and between the Registrant and Dr. Peter Kaiser, dated as of March 28, 2024 |
|---|
| 2024-11-14 | 10-Q | 10.2 | Employment Agreement, by and between the Registrant and Dr. Peter Kaiser, dated as of February 21, 2024 |
|---|
| 2024-11-14 | 10-Q | 10.1 | Employment Agreement, by and between the Registrant and Dr. Jeffrey Heier, dated as of February 21, 2024 |
|---|
| 2024-08-07 | 10-Q | 10.6 | Letter Agreement, by and between the Registrant and Nadia Waheed, dated April 22, 2024 |
|---|
| 2024-08-07 | 10-Q | 10.5 | Employment Agreement, by and between the Registrant and Nadia Waheed, dated April 15, 2024 |
|---|
| 2024-08-07 | 10-Q | 10.4 | Separation Agreement, by and between the Registrant and Rabia Gurses-Ozden, dated May 29, 2024 |
|---|
| 2024-08-07 | 10-Q | 10.3 | Separation Agreement, by and between the Registrant and Antony C. Mattessich, dated May 1, 2024 |
|---|
| 2024-05-07 | 10-Q | 10.8 | Amendment to Employment Agreement, by and between the Registrant and Rabia Gurses Ozden, dated as of March 14, 2024 |
|---|
| 2024-05-07 | 10-Q | 10.7 | Amended and Restated License Agreement, dated January 27, 2012, between the Registrant and Incept LLC |
|---|
| 2024-03-11 | 10-K | 10.42 | Employment Agreement, by and between the Registrant and Dr. Sanjay Nayak, dated as of February 21, 2024 |
|---|
| 2024-03-11 | 10-K | 10.37 | Form of Restricted Stock Unit Agreement under 2021 Stock Incentive Plan |
|---|
| 2024-03-11 | 10-K | 10.12 | Form of Restricted Stock Unit Agreement under 2019 Inducement Stock Incentive Plan |
|---|
| 2024-02-22 | 8-K | 10.5 | Amendment No. 2 to 2019 Inducement Stock Incentive Plan |
|---|
| 2024-02-22 | 8-K | 10.4 | Amendment to Employment Agreement, by and between the Company and Antony Mattessich, dated as of February 21, 2024 |
|---|
| 2024-02-22 | 8-K | 10.3 | Employment Agreement, by and between the Company and Dr. Pravin U. Dugel, dated as of February 21, 2024 |
|---|
| 2024-02-22 | 8-K | 10.2 | Registration Rights Agreement, dated February 21, 2024, by and among the Company and the other parties thereto |
|---|
| 2024-02-22 | 8-K | 10.1 | Securities Purchase Agreement, dated February 21, 2024, by and among the Company and the other parties thereto |
|---|
| 2023-11-07 | 10-Q | 10.3 | Amendment No. 1 to Employee Stock Purchase Plan, effective October 4, 2023. |
|---|
| 2023-11-07 | 10-Q | 10.2 | Amendment No. 1 to Senior Subordinated Convertible Note, dated as of August 2, 2023, between the Registrant and the holders thereof. |
|---|
| 2023-11-07 | 10-Q | 10.1 | Credit and Security Agreement, dated August 2, 2023, by and among Barings Finance LLC, as administrative agent, the Registrant, and the Lenders listed therein. |
|---|
| 2023-08-07 | 10-Q | 10.2 | 2021 Stock Incentive Plan, as amended |
|---|
| 2023-08-07 | 10-Q | 10.1 | Amendment No. 2 to Fourth Amended and Restated Credit and Security Agreement, dated May 4, 2023, by and among MidCap Financial Trust, as administrative agent, the Registrant, and the Lenders listed therein. |
|---|
| 2023-07-07 | 8-K | 10.1 | Third Amendment to Lease, by and between Ocular Therapeutix, Inc. and Cobalt PropCo 2020, LLC, dated June 30, 2023 |
|---|
| 2023-05-08 | 10-Q | 10.1 | Amendment No. 1 to Fourth Amended and Restated Credit and Security Agreement, dated March 31, 2023, by and among MidCap Financial Trust, as administrative agent, the Registrant, and the Lenders listed therein. |
|---|
| 2023-03-06 | 10-K | 10.45 | Employment Agreement, by and between the Registrant and Christopher White, dated as of October 13, 2022 |
|---|
| 2023-03-06 | 10-K | 10.44 | Employment Agreement, by and between the Registrant and Rabia Ozden-Gurses, dated as of September 28, 2022 |
|---|
| 2023-03-06 | 10-K | 10.43 | Consulting Agreement by and between the Registrant and Dr. Jeffrey Heier, dated as of October 17, 2022 |
|---|
| 2022-08-08 | 10-Q | 10.2 | Consulting Agreement by and between the Registrant and Dr. Michael Goldstein, dated as of June 7, 2022. |
|---|
| 2022-08-08 | 10-Q | 10.1 | 2021 Stock Incentive Plan, as amended |
|---|
| 2022-02-28 | 10-K | 10.41 | Amendment No. 1 to License Agreement, by and between the Registrant and AffaMed Therapeutics (HK) Limited, dated as of October 28, 2021 |
|---|
| 2022-02-28 | 10-K | 10.40 | Form of Restricted Stock Unit Agreement under 2021 Stock Incentive Plan |
|---|
| 2022-02-28 | 10-K | 10.39 | Form of Option Grant Agreement under 2021 Stock Incentive Plan |
|---|
| 2021-06-04 | 8-K | 10.1 | Fourth Amended and Restated Credit and Security Agreement dated June 4, 2021 by and among MidCap Financial Trust, as administrative agent, Ocular Therapeutix, Inc., and the Lenders listed therein |
|---|
| 2021-03-11 | 10-K | 10.36 | Supplement to License Agreement, by and between the Registrant and AffaMed Therapeutics Limited, dated as of January 18, 2021 |
|---|
| 2021-03-11 | 10-K | 10.19 | Employment Agreement, by and between the Registrant and Philip Strassburger, dated August 28, 2020 |
|---|
| 2021-03-11 | 10-K | 10.9 | Amendment to 2019 Inducement Stock Incentive Plan |
|---|
| 2020-11-05 | 10-Q | 10.1 | License Agreement, by and between the Registrant and AffaMed Therapeutics Limited, dated October 29, 2020. |
|---|
| 2020-05-14 | 8-K | 10.1 | Amendment to Collaboration, Option and License Agreement, by and between the Company and Regeneron, dated May 8, 2020. |
|---|
| 2020-05-08 | 10-Q | 10.1 | Employment Agreement, by and between the Registrant and Patricia Kitchen, dated as April 21, 2019. |
|---|
| 2020-03-12 | 10-K | 10.27 | Separation and Release of Claims Agreement by and between the Registrant and Daniel Bollag, dated December 2, 2019 |
|---|
| 2019-11-12 | 10-Q | 10.2 | Form of Inducement Nonstatutory Stock Option Agreement. |
|---|
| 2019-11-12 | 10-Q | 10.1 | 2019 Inducement Stock Incentive Plan. |
|---|
| 2019-08-07 | 10-Q | 10.7 | Consulting Agreement by and between Ocular Therapeutix, Inc. and Kevin Hanley, dated as of August 2, 2019. |
|---|
| 2019-08-07 | 10-Q | 10.6 | Transition, Separation and Release of Claims Agreement by and between Ocular Therapeutix, Inc. and Kevin Hanley, dated as of August 2, 2019. |
|---|
| 2019-08-07 | 10-Q | 10.5 | Second Amendment to Third Amended and Restated Credit and Security Agreement, by and among Ocular Therapeutix, Inc., MidCap Financial Trust as administrative agent, and the Lenders listed therein. |
|---|
| 2019-05-30 | 8-K | 10.2 | Consulting Agreement by and between Ocular Therapeutix, Inc. and Dr. Amarpreet S. Sawhney, dated as of May 29, 2019. |
|---|
| 2019-05-30 | 8-K | 10.1 | Transition, Separation and Release of Claims Agreement by and between Ocular Therapeutix, Inc. and Dr. Amarpreet S. Sawhney, dated as of May 29, 2019. |
|---|
| 2019-05-10 | 10-Q | 10.4 | Sublease, dated as of April 4, 2019, by and among Ocular Therapeutix, Inc. and Holcim (US) Inc. |
|---|
| 2019-02-22 | 8-K | 10.4 | Subordination Agreement, dated as of February 21, 2019, by and among Ocular Therapeutix, Inc., MidCap Financial Trust, as administrative agent, and the Lenders listed therein. |
|---|
| 2019-02-22 | 8-K | 10.3 | First Amendment to Third Amended and Restated Credit and Security Agreement, dated as of February 21, 2019, by and among Ocular Therapeutix, Inc., MidCap Financial Trust, as administrative agent, and the Lenders listed therein. |
|---|
| 2019-02-22 | 8-K | 10.2 | Form of Registration Rights Agreement by and among Ocular Therapeutix, Inc. and the Purchasers listed therein. |
|---|
| 2019-02-22 | 8-K | 10.1 | Note Purchase Agreement (including Form of Senior Subordinated Convertible Note), dated as of February 21, 2019, by and among Ocular Therapeutix, Inc. and the Purchasers listed therein. |
|---|
| 2018-12-28 | 8-K | 10.1 | Third Amended and Restated Credit and Security Agreement dated December 21, 2018 by and among MidCap Financial Trust, as administrative agent, Ocular Therapeutix, Inc., and the Lenders listed therein. |
|---|
| 2018-09-19 | 8-K | 10.1 | Second Amended and Restated License Agreement, dated September 13, 2018, by and between Ocular Therapeutix, Inc. and Incept LLC. |
|---|
| 2018-08-07 | 10-Q | 10.1 | Second Amendment to Employment Agreement, by and between Ocular Therapeutix, Inc. and Amarpreet S. Sawhney, dated August 6, 2018 |
|---|
| 2018-03-08 | 10-K | 10.31 | Employment Agreement, by and between Ocular Therapeutix, Inc. and Kevin Hanley, dated as of January 5, 2018 |
|---|
| 2018-03-08 | 10-K | 10.30 | Employment Agreement, by and between Ocular Therapeutix, Inc. and Michael Goldstein, dated as of September 25, 2017 |
|---|
| 2018-03-08 | 10-K | 10.29 | Employment Agreement, by and between Ocular Therapeutix, Inc. and Daniel Bollag, dated as of July 31, 2017 |
|---|
| 2017-10-16 | 8-K | 10.1 | Second Amendment to Lease, by and between Ocular Therapeutix, Inc. and CCC Investors LLC, dated October 10, 2017. |
|---|
| 2017-10-13 | 8-K | 10.1 | Transition, Separation and Release of Claims Agreement by and between Ocular Therapeutix, Inc. and James Fortune, dated as of October 13, 2017 |
|---|
| 2017-09-25 | 8-K | 10.1 | Employment Agreement, by and between Ocular Therapeutix, Inc. and Donald Notman, dated as of September 25, 2017 |
|---|
| 2017-08-08 | 10-Q | 10.4 | Offer Letter Agreement, by and between Ocular Therapeutix, Inc. and George Migausky, dated as of April 6, 2017 |
|---|
| 2017-08-03 | 8-K | 10.2 | Consulting Agreement by and between Ocular Therapeutix, Inc. and Anchor Biotech Consulting, LLC, dated as of July 31, 2017 |
|---|
| 2017-08-03 | 8-K | 10.1 | Transition, Separation and Release of Claims Agreement by and between Ocular Therapeutix, Inc. and Eric Ankerud, dated as of July 31, 2017 |
|---|
| 2017-06-22 | 8-K | 10.3 | Non-Statutory Stock Option Agreement, by and between Ocular Therapeutix, Inc. and Antony C. Mattessich, dated as of June 20, 2017 |
|---|
| 2017-06-22 | 8-K | 10.2 | Employment Agreement, by and between Ocular Therapeutix, Inc. and Antony C. Mattessich, dated as of June 20, 2017 |
|---|
| 2017-06-22 | 8-K | 10.1 | Amendment to Employment Agreement, by and between Ocular Therapeutix, Inc. and Amarpreet S. Sawhney, dated as of June 20, 2017 |
|---|
| 2017-05-05 | 10-Q | 10.1 | Second Amended and Restated Credit and Security Agreement, dated March 7, 2017, by and among the MidCap Financial Trust, the Registrant, and the Lenders listed therein. |
|---|
| 2016-11-09 | 10-Q | 10.3 | Employment Agreement, dated October 10, 2016, by and between the Company and Andrew Hurley |
|---|
| 2016-11-09 | 10-Q | 10.2 | Employment Agreement, dated January 5, 2016, by and between the Company and Jonathan H. Talamo, M.D. |
|---|
| 2016-11-09 | 10-Q | 10.1 | Collaboration, Option and License Agreement between Ocular Therapeutix, Inc. and Regeneron Pharmaceuticals, Inc. dated October 10, 2016 |
|---|
| 2016-08-09 | 10-Q | 10.2 | First Amendment dated June 20, 2016 to Amended and Restated Credit and Security Agreement among MidCap Funding III Trust, Silicon Valley Bank, Flexpoint MCLS SPV LLC and the Registrant |
|---|
| 2016-08-09 | 10-Q | 10.1 | Lease Agreement dated June 17, 2016 between the WS NF 15 Crosby Drive, LLC and the Registrant |
|---|
| 2015-12-09 | 8-K | 10.1 | Amended and Restated Credit and Security Agreement, by and among MidCap Funding III Trust, as administrative agent, Silicon Valley Bank, Flexpoint MCLS SPV LLC and Ocular Therapeutix, Inc., dated December 3, 2015. |
|---|